miR-130a的表达与双管主动脉儿童的大动脉扩张有关
Borja Antequera-González1, Rosa Collell-Hernández2, Neus Martínez-Micaelo1
1Group of Cardiovascular Research, Pere Virgili Health Research Institute (IISPV), Universitat Rovira i Virgili, 43204, Reus, Spain.
Pediatric research
|January 25, 2024
概括
患有双主动脉 (BAV) 疾病的儿童中较低的miR-130a血水平表明主动脉扩张. 这一发现可能有助于识别高风险的儿科BAV患者,以便更好地规划护理.
科学领域:
- 心血管研究研究心血管研究
- 儿童心脏病学 儿童心脏病学
- 分子生物学分子生物学
背景情况:
- 双大动脉 (BAV) 疾病影响0.5-2%的人口,可能导致致命的大动脉扩张.
- 虽然存在成人生物标志物,但在儿科BAV患者中没有一个得到验证.
- 这项研究研究了BAV和大动脉扩张的儿童中的四种候选microRNA (miRNA).
研究的目的:
- 在患有BAV的儿科队列中评估miR-122,miR-130a,miR-486和miR-718的血水平.
- 为了确定这些miRNA是否与儿童的大动脉扩张相关.
- 探索与已识别的miRNAs相关的功能途径.
主要方法:
- 4-17岁的80名参与者被录取,其中40%的BAV患者表现出大动脉扩张 (z评分>2).
- 用RT-qPCR分析血样本以量化四种特定的miRNAs.
- 对miR-130a进行了功能和丰富分析.
主要成果:
- 与非扩张的BAV患者和健康对照患者相比,大动脉扩张的BAV患者的血miR-130a水平显着较低.
- miR-130a表达与上升性大动脉和大动脉根z分数呈反相关性.
- 丰富分析表明,miR-130a的点参与了TGFβ信号通路.
结论:
- 血miR-130a表达的降低与儿科BAV患者的大动脉扩张有关.
- miR-130a可以作为一种有价值的生物标志物,用于区分患有BAV的儿童的风险水平.
- 这项研究是首次分析大动脉扩张的儿科BAV患者的miRNA模式,有助于风险分层和护理规划.
相关概念视频
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


